Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Orion Group Holdings, Inc.NYSE: ORN
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue growth accelerates
Q1 FY2026 revenue of $216.3M rose 14.7% year over year, ahead of the +6.7% change in trailing-twelve-month revenue. Sequentially, it fell 7.3% from the prior quarter. Over 3 fiscal years it compounded at +4.4% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of $942.06M (+10.5%) for the fiscal year ending Dec 2026, a step up from the +7.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $216.3M-7.3% QoQ
- Last fiscal yearDec 2025
- $852.26M+7.0% YoY
- LTMMar 2026
- $879.91M+6.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +14.7% | +10.0% | -4.7 pp |
| 1 year | +7.0% | +10.5% | +3.5 pp |
| 3-year CAGR | +4.4% | +11.4% | +6.9 pp |
| 5-year CAGR | +6.7% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 852.26M USD
- Year-over-year change
- +7.0%
- 4-year CAGR
- +9.1%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 852.26M | +7.0% |
| FY2024 | 2024-12-31 | 796.39M | +11.9% |
| FY2023 | 2023-12-31 | 711.78M | -4.9% |
| FY2022 | 2022-12-31 | 748.32M | +24.4% |
| FY2021 | 2021-12-31 | 601.36M | — |
Revenue vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of +6.7% is the 6th highest of 10, against a peer median of +10.4%.
- Over three fiscal years its annual growth of +4.4% compares with a peer median of +2.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Apr 2026 | $1.54B USD | -11.1% | -8.2% | |
| LTM Mar 2026 | $879.91M USD | +6.7% | +4.4% | |
| LTM Mar 2026 | $845.48M USD | +13.9% | +2.8% | |
| LTM Apr 2026 | $523.85M USD | +10.4% | +3.0% | |
| LTM Apr 2026 | $409.82M USD | +2.1% | -0.7% | |
| LTM Feb 2026 | $392.4M USD | -0.6% | -3.1% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $254.27M USD | +1.1% | +10.5% |
| LTM Feb 2026 | $120.98M USD | +27.0% | +35.0% | |
| LTM Mar 2026 | $73.3M USD | +18.2% | +10.7% | |
| LTM Mar 2026 | $18.56M USD | +167.6% | -2.3% | |
| LTM Mar 2026 | £0 GBP | — | — | |
| Peer median (excluding ORN) | — | +10.4% | +2.8% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 601.36M | 748.32M | 711.78M | 796.39M | 852.26M |
| Cost of Revenue | 560.39M | 697.58M | 650.12M | 705.23M | 746.65M |
| Gross Profit | 40.97M | 50.74M | 61.66M | 91.16M | 105.61M |
| Gross Margin | 6.8% | 6.8% | 8.7% | 11.4% | 12.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 60.18M | 62.5M | 69.43M | 82.54M | 93.47M |
| Operating Expenses | 50.28M | 58.77M | 68.29M | 79.64M | 93.47M |
| Depreciation & Amortization | 25.43M | 24.06M | 23.88M | 22.77M | 30.52M |
| EBITDA | 4.7M | 11.06M | 15.68M | 31.39M | 42.29M |
| EBITDA Margin | 0.8% | 1.5% | 2.2% | 3.9% | 5.0% |
| Operating Income | (9.32M) | (8.03M) | (6.63M) | 11.52M | 12.14M |
| Operating Margin | -1.5% | -1.1% | -0.9% | 1.4% | 1.4% |
| Interest Income | 136K | 104K | 103K | 207K | 0 |
| Interest Expense | 5.08M | 4.46M | 11.66M | 13.38M | 8.56M |
| Other Income / Expenses | (4.74M) | (4.15M) | (10.92M) | (12.82M) | (9.24M) |
| Income Before Tax | (14.06M) | (12.18M) | (17.55M) | (1.3M) | 2.91M |
| Pre-Tax Margin | -2.3% | -1.6% | -2.5% | -0.2% | 0.3% |
| Income Tax Expense | 502K | 429K | 330K | 348K | 419K |
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Net Margin | -2.4% | -1.7% | -2.5% | -0.2% | 0.3% |
| EPS (Basic) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| EPS (Diluted) | (0.47) | (0.40) | (0.55) | (0.05) | 0.06 |
| Weighted Avg Shares | 30.76M | 31.4M | 32.35M | 34.78M | 39.63M |
| Weighted Avg Shares (Diluted) | 30.76M | 31.4M | 32.35M | 34.78M | 39.64M |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.